...
首页> 外文期刊>Vaccine >Oral administration of PLGA-encapsulated CpG ODN and Campylobacter jejuni lysate reduces cecal colonization by Campylobacter jejuni in chickens
【24h】

Oral administration of PLGA-encapsulated CpG ODN and Campylobacter jejuni lysate reduces cecal colonization by Campylobacter jejuni in chickens

机译:PLGA包装的CPG ODN和Campylobacter jejuni裂解物的口服给药降低了鸡的Campylobacter jejuni的盲肠殖民化

获取原文
获取原文并翻译 | 示例
           

摘要

Campylobacter jejuni (C. jejuni) is a major cause of bacterial food -borne illness in humans. It is considered a commensal organism of the chicken gut and infected chickens serve as a reservoir and shed bacteria throughout their lifespan. Contaminated poultry products are considered the major source of infection in humans. Therefore, to reduce the risk of human campylobacteriosis, it is essential to reduce the bacterial load in poultry products. The present study aimed to evaluate the protective effects of soluble and PLGA-encapsulated oligodeoxynucleotides (ODN) containing unmethylated CpG motifs (E-CpG ODN) as well as C. jejuni lysate as a multi-antigen vaccine against colonization with C. jejuni. The results revealed that oral administration of a low (5 mu g) or high (50 mu g) dose of CpG resulted in a significant reduction in cecal C. jejuni colonization by 1.23 and 1.32 log(10) (P .05) in layer chickens, respectively, whereas E-CpG significantly reduced cecal C. jejuni colonization by 1.89 and 1.46 log(10) in layer and broiler chickens at day 22 post-infection (slaughter age in broilers), respectively. Similar patterns were observed for C. jejuni lysate; oral administration of C. jejuni lysate reduced the intestinal burden of C. jejuni in layer and broiler chickens by 2.24 and 2.14 log(10) at day 22 post-infection, respectively. Moreover, the combination of ECpG and C. jejuni lysate reduced bacterial counts in cecal contents by 2.42 log(10) at day 22 post infection in broiler chickens. Anti-C jejuni IgG antibody (Ab) titers were significantly higher for broiler chickens receiving a low or high dose of E-CpG or a low dose of C. jejuni lysate than for chickens receiving the placebo. Furthermore, a positive correlation was observed between serum IgG Ab titers and cecal counts of C. jejuni in these groups. These findings suggest that PLGA-encapsulated CpG or C. jejuni lysate could be a promising strategy for control of C. jejuni in chickens. (C) 2017 Elsevier Ltd. All rights reserved.
机译:Campylobacter Jejuni(C.Jejuni)是人类细菌食品的主要原因。它被认为是鸡肠道的共生生物,受感染的鸡作为整个寿命的储层和脱落的细菌。受污染的家禽产品被认为是人类感染的主要来源。因此,为了降低人类振动杆菌的风险,重要的是减少家禽产品中的细菌负荷。本研究旨在评估含有未甲基化的CpG基序(E-CpG ODN)的可溶性和PLGA包封的寡核苷酸(ODN)以及C.Jejuni裂解物作为与C.Jejuni的定子的多抗原疫苗的C.Jejuni裂解物。结果表明,口服施用低(5μg)或高(50μg)的CPG剂量导致杂志C. Jejuni定子的显着降低1.23和1.32 Log(10)(P <.05)在第22天分别在第22天,E-CPG分别在第22天(肉鸡)后的第22层和肉鸡鸡中,E-Cpg分别将肠和1.46对数(10)显着降低了CeNal C. Jejuni定位。观察到类似的模式为C.Jejuni裂解物;口服给予C. Jejuni裂解物在第22天在感染后的第22天将C. Jejuni的肠道和2.14日志(10)降低了C. Jejuni的肠道毛。此外,ECPG和C.Jejuni裂解物的组合在肉鸡鸡的第22天在第22天感染后22天的肠含量减少了肠内含量的细菌计数。对于接受安慰剂的鸡,抗C jejuni IgG抗体(Ab)滴度显着高于接受低剂量的e-cpg或低剂量的C.Jejuni裂解物。此外,在这些组中血清IgG AB滴度和C.Jejuni的CeCal计数之间观察到阳性相关性。这些研究结果表明,PLGA封装的CPG或C.Jejuni裂解物可能是鸡中C. jejuni控制的有希望的策略。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号